CRVL logo

CORVEL CORP

CRVLNASDAQ
πŸ† #1530 by market capUS Equity
$669.73β–² $24.38 (+3.64%)
Simulated price
πŸ””
Track CRVL
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 3.6%
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$3.79B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+7.0%
Slowing
πŸ“ŠGross Margin
23.9%
Moderate
πŸ’΅FCF Margin
11.6%
Healthy
βš–οΈP/S Ratio
3.9x
Fair
Otter Score
56
Weak
No chart data available for CRVL.

Trading Snapshot

Day Range
$660.78 – $677.64
52-Week Range
$44.83 – $79.43
Volume
$3.19B
Avg Volume
$2.28B
Shares Outstanding
51.0M
Next Earnings
Nov 8, 2026

Fundamentals Snapshot

Annual Revenue
$959M
Last Q Revenue
$260M
P/E Ratio
33.0
P/S Ratio
3.9x
EPS (TTM)
$2.27
Dividend Yield
0.00%
Dilution (1yr)
βˆ’1.3%

Why Investors Own CRVL

  • βœ“High-growth profile β€” revenue up +0.1% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 30% gross margin and 21% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

CRVL logo

CORVEL CORP

CRVL
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$959Mβ–² +7.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
24.3%β–² +3.7% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$143Mβ–² +18.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$110Mβ–² +20.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
50.9Mβ–Ό βˆ’1.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$227Mβ–² +$42M YoY
StockOtter Β· stockotter.space

About CORVEL CORP

CorVel Corporation delivers comprehensive solutions designed to assist employers, third-party administrators, insurance providers, and government entities in effectively managing healthcare claims. The company focuses on controlling medical expenditures and ensuring high-quality care across various sectors, including workers' compensation, auto liability, and general health. Leveraging advanced technologies such as artificial intelligence, machine learning, and natural language processing, CorVel enhances the oversight of entire healthcare episodes and their associated costs. Their service portfolio includes a wide array of network solutions, featuring automated medical fee auditing, management and reimbursement for preferred providers, retrospective utilization reviews, and detailed scrutiny of both facility and professional claims. Additionally, they offer pharmacy services, directed care programs, Medicare solutions, clearinghouse functionalities, independent medical examinations, and inpatient medical bill reviews. Beyond network services, CorVel provides a suite of patient management offerings, encompassing claims and case management, round-the-clock nurse triage, utilization management, vocational rehabilitation, and life care planning. The company also processes property and casualty claims specifically for self-insured clients. Established in 1987, CorVel maintains its corporate headquarters in Fort Worth, Texas.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
56/100

Analyst Price Target

β“˜
Average Target
$753.03
β–² +12.4% Upside
High Target$902.60
Low Target$666.98
Based on 20 analysts

Latest News & Updates